Abstract 

Background. Chronic kidney disease (CKD) is renal dysfunction leads to failure in the body's ability to maintain metabolic, fluid electrolytes, and balance. It mostly results in uremia or azotemia and can be classified into stages 1 to 5 based on the deterioration of glomerular filtration rate (GFR. These complications lead to the deficiency of erythropoietin (EPO) possible iron loss in patients on hemodialysis are considered the main factors in contributing anemia in CKD patients. Aims: This study aims to evaluate the prevalence of anemia in CKD patients aged 18 years and above. Methods: A cross-sectional study was performed on 90 participants from patients with confirmed stage 5 of CKD who were on follow-up at the dialysis unit of Sabratha and Surman Hospitals.
Results: The prevalence of anemia in dialysis patients’ was found to be extremely high as 97.8% (88/90), and the most effected patients belonged to age group 45-64 (54.4%). Interestingly, elderly (65-84) years old patients was the least affected group (17,8%)‎ which also showed only one case of severe anemia (hemoglobin < 7 g/dl)
Conclusion: This study is strongly confirms the suggestions of anemia contributions in CKD patient spatially in late stages.
Recommendations: According to the high incidence of anemia among CKD patients, its highly recommended that routine hemoglobin checkups must be followed, and diet supplements might be required to replace the iron loose.